Beranda › Sistem Imun dan Gangguan › Texas › Houston
Uji klinis Sistem Imun dan Gangguan di Houston, TX
9 studi untuk Sistem Imun dan Gangguan mencari peserta di lokasi sekitar Houston (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Menerima pesertaFase 1
- The University of Texas - MD Anderson Cancer Center, Houston
A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
Menerima pesertaFase 2
- Jade Clinical Site, Houston
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Menerima pesertaFase 3
- Baylor College of Medicine, Houston
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Menerima pesertaFase 2
- The University of Texas MD Anderson Cancer Center, Houston
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Menerima pesertaFase 3
- Baylor College of Medicine, Houston
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Menerima pesertaFase 3
- Nephro Asso North Illinois Indiana, Houston
A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition
Menerima pesertaFase 2
- Texas Children's Hospital, Houston
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
Menerima pesertaFase 1/2
- MD Anderson Texas Medical Center, Houston
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Menerima pesertaFase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Uji klinis Sistem Imun dan Gangguan di kota lain
- Washington, DC13 studi
- New York City, NY12 studi
- Boston, MA10 studi
- Philadelphia, PA10 studi
- Atlanta, GA9 studi
- Portland, OR9 studi
- Cleveland, OH8 studi
- Chicago, IL8 studi
- Los Angeles, CA8 studi
- Milwaukee, WI6 studi
- Seattle, WA6 studi
- Cedar Rapids, IA6 studi
Studi lain di Houston
- Kanker Paru Non-Sel Kecil145 studi
- Kanker Payudara126 studi
- Kanker (semua jenis)121 studi
- Kanker Metastatik104 studi
- Kanker Kolorektal102 studi
- Kanker Ovarium89 studi
- Leukemia Mieloid Akut85 studi
- Kanker Paru78 studi
- Kanker Prostat76 studi
- Kanker Endometrium68 studi
- Kanker Pankreas61 studi
- Melanoma59 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.